Multiple Myeloma in Relapse Available Phase Trials for Ulocuplumab (DB12018)

IndicationStatusPhase
DBCOND0036092 (Multiple Myeloma in Relapse)AvailableNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02666209Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple Myeloma